Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Next quarterly report next week?

<< Previous

Bullboard Posts

Next >>

Comment by Yajneon Feb 22, 2023 5:21pm

165 Views

Post# 35299438

RE:Next quarterly report next week?

I also they will provide a quarterly update for the clinical trial...but don't expect Q4 financials which will be released with full year financials end of April. Actually May 1 is the deadline for venture based companies this year.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project